82
Participants
Start Date
April 30, 2011
Primary Completion Date
June 30, 2012
Study Completion Date
August 31, 2012
CNV1014802
Administered as specified in treatment arm.
Placebo
Administered as specified in treatment arm
Research Site, Brno
Research Site, Litoměřice
Research Site, Prachatice
Research Site, Glostrup Municipality
Research Site, Odense
Research Site, Lille
Research Site, Nice
Research Site, Paris
Research Site, Saint-Etienne
Research Site, Gothenburg
Research Site, Malmo
Research Site, Stockholm
Lead Sponsor
Biogen
INDUSTRY